Our very successful series of online lunchtime seminars is continuing in the Summer term of 2021 with an exciting programme of events. The events take place on Wednesdays lunchtime.
In ther article recently published on JOIE, Dr Luca Andriani and colleagues investigate whether tax morale, an individual’s intrinsic non-pecuniary motivation to comply with taxes, is associated with the cultural values held by the individual.
This event is the second in a series to be co-hosted by Essex Business School, University of Essex and Birkbeck, University of London.
Dr Gaby Slavcheva and Dr Mirella Koleva are not your average mother and daughter. Both holding PhDs in science, the pair moved away from academia to found Quantopticon, a company which aims to rapidly speed up the development of quantum components to bring this exciting new technology to market.
This timely debate was well-attended by experts in related fields, from practitioners to scholars in different stages of their career.
Academics, practitioners and policymakers came together for an online discussion that shared insights into the research on inclusive innovation.
Professors Daniele Archibugi (Birkbeck, University of London) and Suma Athreye (University of Essex) will outline slightly different views about the role of public research in this discovery, which we want to use as a starting point for scholarly debate on the extent to which vaccine development can serve as a template for future innovation policy.
This book aims to develop a conceptual framework to evaluate knowledge transfer practices and outcomes, improve knowledge transfer metrics, surveys and evaluation frameworks, generate findings on what does and does not work, and propose related policy lessons.
Thanos Fragkandreas, Goethe University of Frankfurt and Centre for Innovation Management Research shared his research into the relationship between innovation and inequality at our latest Debate in Public Policy.
Vaccines to combat the threat of Covid-19 have been developed at an amazing speed – in under a year. And while the first vaccines to be approved came from the private sector using new mRNA technologies, the unsung heroes of the COVD-19 vaccine effort have been the publicly funded national universities and laboratories.